| Literature DB >> 34468888 |
Katrin Bekes1, Stefanie Amend2, Julia Priller3, Claudia Zamek4, Tanja Stamm5, Norbert Krämer2.
Abstract
OBJECTIVES: The aim of this study was to compare the efficacy in reducing hypersensitivity in molar incisor hypomineralization (MIH)-affected molars immediately and over 12 weeks after sealing using two different materials (composite and glass ionomer). Furthermore, the retention rates of both materials were analyzed.Entities:
Keywords: Composite; Glass ionomer cement; Hypersensitivity; Molar incisor hypomineralization (MIH); Sealing
Mesh:
Year: 2021 PMID: 34468888 PMCID: PMC8816787 DOI: 10.1007/s00784-021-04163-5
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.573
Compositions of the materials used
| Material | Composition |
|---|---|
| Scotchbond™ Universal | 2-Hydroxyethyl methacrylate; bisphenol a diglycidyl ether dimethacrylate (BISGMA), 2-propenoic acid, 2-methyl-, reaction products with 1,10-decanediol and phosphorous oxide (P2O5); ethanol; water; 2-propenoic acid, 2-methyl-, 3-(trimethoxysilyl)propyl ester with vitreous silica; copolymer of acrylic and itaconic acid; camphorquinone dimethylaminobenzoate(-4); (dimethylamino)ethyl methacrylate |
| Clinpro™ Sealant | Triethylene glycol dimethacrylate (TEGDMA); bisphenol a diglycidyl ether dimethacrylate (BISGMA); silane-treated silica; tetrabutylammonium tetrafluoroborate; diphenyliodonium hexafluorophosphate; triphenylantimony; ethyl 4-dimethyl aminobenzoate (EDMAB); titanium dioxide hydroquinone |
| Ketac™ Universal Aplicap™ | Liquid: water; copolymer of acrylic acid-maleic acid; tartaric acid; benzoic acid Powder: oxide glass chemicals |
Criteria used for the evaluation of the fissure sealants
| Category | Scores | Criteria |
|---|---|---|
| Retention | Alpha Bravo Charlie | No loss of sealing material Partial loss of sealing material Loss of restorative material |
| Marginal adaption | Alpha Bravo Charlie | Closely adapted, no visible crevice Visible crevice, explorer will penetrate Crevice in which dentin is exposed |
| Marginal discoloration | Alpha Bravo Charlie | No discoloration Discoloration without penetration in pulpal direction Discoloration with penetration in pulpal direction |
| Surface texture—optical | Alpha Bravo | Shiny Dull |
| Surface texture—tactile | Alpha Bravo Charlie | Enamel-like surface Surface rougher than enamel, clinically acceptable Surface unacceptably rough |
| Caries | Alpha Charlie | No caries present Caries present |
Fig. 1Sealings in a patient in the upper jaw at baseline and after 12 weeks. a Tooth 16 at baseline. b tooth 16 after sealing with Clinpro™ Sealant. c tooth 16 after 12 weeks. d tooth 26 at baseline. d tooth 26 after sealing with Ketac™ Universal. e tooth 26 after 12 weeks
General characteristics of participants (N=39)
| Patient variable | |
|---|---|
| Age (years) | 7.5 (1.3, 6–10) |
| Gender | |
| Male | 21 (53.8) |
| Female | 18 (46.2) |
| Caries index | |
| dmft | 0.38 (±1.44; 0–8) |
| DMFT | 0.21 (±0.41; 0–1) |
Mean scores and standard deviations for the air blast test (Schiff score) and the tactile test (Wong-Baker Faces Scale) at different time points
| SCASS | VAS | |||
|---|---|---|---|---|
| Clinpro | Ketac | Clinpro | Ketac | |
| Before treatment (pre) | 2.3 (±0.5) | 2.4 (±0.5) | 7.1 (±1.7) | 7.1 (±2.0) |
| After treatment (post) | 0.4 (±0.6) | 0.4 (±0.7) | 1.2 (±1.7) | 1.1 (±1.8) |
| After 1 week | 0.3 (±0.7) | 0.3 (±0.7) | 1.2 (±1.9) | 1.1 (±1.8) |
| After 4 weeks | 0.2 (±0.6) | 0.3 (±0.7) | 0.8 (±1.3) | 1.1 (±1.9) |
| After 8 weeks | 0.2 (±0.5) | 0.3 (±0.7) | 0.7 (±1.2) | 0.7 (±1.5) |
| After 12 weeks | 0.1 (±0.4) | 0.1 (±0.5) | 0.8 (±1.4) | 0.8 (±1.3) |
Changes in SCASS and VAS and related effect sizes at different time points
| Clinpro | Ketac | |||||||
|---|---|---|---|---|---|---|---|---|
| Change score mean (SD) | Effect size | Description | Change score mean (SD) | Effect size | Description | |||
| Baseline | ||||||||
Immediately post 1 week post | <0.001 <0.001 | 1.9 (±0.8) 2.1 (±0.8) | 2.4 2.6 | Large Large | <0.001 <0.001 | 2.0 (±0.7) 2.0 (±0.9) | 2.9 2.2 | Large Large |
| 4 weeks post | <0.001 | 2.1 (±0.8) | 2.6 | Large | <0.001 | 2.0 (±0.8) | 2.5 | Large |
| 8 weeks post | <0.001 | 2.2 (±0.7) | 3.1 | Large | <0.001 | 2.1 (±0.7) | 3 | Large |
| 12 weeks post | <0.001 | 2.2 (±0.6) | 3.7 | Large | <0.001 | 2.2 (±0.6) | 3.7 | Large |
| Immediately post | ||||||||
1 week post 4 weeks post | =0.324 =0.147 | 0.1 (±0.6) 0.2 (±0.7) | 0.2 0.3 | Small Small | =0.661 =0.700 | 0.1 (±0.7) 0.1 (±0.8) | 0.1 0.1 | Small |
| 8 weeks post | =0.088 | 0.2 (±0.7) | 0.3 | Small | =0.244 | 0.2 (±0.8) | 0.3 | Small |
| 12 weeks post | =0.010 | 0.3 (±0.7) | 0.4 | Moderate | =0.023 | 0.3 (±0.7) | 0.4 | Moderate |
| 1 week post | ||||||||
| 4 weeks post | =0.597 | 0.1 (±0.9) | 0.1 | =1 | 0 (±1.0) | |||
| 8 weeks post | =0.457 | 0.1 (±0.9) | 0.1 | =0.457 | 0.1 (±0.9) | 0.1 | ||
| 12 weeks post | =0.090 | 0.2 (±0.7) | 0.3 | Small | =0.088 | 0.2 (±0.7) | 0.3 | Small |
| 4 weeks post | ||||||||
| 8 weeks post | =0.324 | 0 (±0.2) | =0.291 | 0.1 (±0.6) | 0.2 | Small | ||
| 12 weeks post | =0.378 | 0.1 (±0.7) | 0.1 | =0.103 | 0.2 (±0.8) | 0.3 | Small | |
| 8 weeks post | ||||||||
| 12 weeks post | =0.474 | 0.1 (±0.7) | 0.1 | =0.401 | 0.1 (±0.8) | 0.1 | ||
| Baseline | ||||||||
immediately post 1 week post | <0.001 <0.001 | 5.8 (±2.4) 5.8 (±2.5) | 2.4 2.3 | Large Large | <0.001 <0.001 | 6.0 (±2.3) 5.9 (±2.0) | 2.6 3.0 | Large Large |
| 4 weeks post | <0.001 | 6.3 (±2.2) | 2.9 | Large | <0.001 | 6.1 (±2.5) | 2.4 | Large |
| 8 weeks post | <0.001 | 6.4 (±2.2) | 2.9 | Large | <0.001 | 6.4 (±2.2) | 2.9 | Large |
| 12 weeks post | <0.001 | 6.2 (±2.0) | 3.1 | Large | <0.001 | 6.2 (±2.1) | 3.0 | Large |
| Immediately post | ||||||||
1 week post 4 weeks post | =0.793 =0.136 | −0.1 (±1.2) 0.5 (±1.9) | 0.1 0.3 | Small Small | =0.918 =0.810 | 0 (±1.6) 0.1 (±2.0) | 0.1 0.1 | Small |
| 8 weeks post | =0.085 | 0.6 (±1.9) | 0.3 | Small | =0.265 | 0.4 (±2.1) | 0.2 | Small |
| 12 weeks post | =0.156 | 0.4 (±1.6) | 0.3 | Small | =0.398 | 0.3 (±1.9) | 0.2 | Small |
| 1 week post | ||||||||
| 4 weeks post | =0.082 | 0.5 (±1.8) | 0.3 | Small | =0.783 | 0.1 (±2.3) | 0 | |
| 8 weeks post | =0.069 | 0.6 (±2.0) | 0.3 | Small | =0.280 | 0.4 (±2.4) | 0.2 | Small |
| 12 weeks post | =0.150 | 0.4 (±1.8) | 0.2 | Small | =0.265 | 0.3 (±1.6) | 0.2 | Small |
| 4 weeks post | ||||||||
| 8 weeks post | =0.539 | 0.1 (±0.8) | 0.1 | =0.083 | 0.3 (±1.1) | 0.3 | Small | |
| 12 weeks post | =0.722 | −0.1 (±1.8) | 0.1 | =0.617 | 0.2 (±2.3) | 0.1 | ||
| 8 weeks post | ||||||||
| 12 weeks post | =0.475 | −0.2 (±1.5) | 0.1 | =0.695 | −0.1 (±2.1) | 0 | ||
Clinical scores of the restorations in both groups according to the modified Ryge criteria. No significant differences between groups were detected (p>0.05)
| Baseline | After 1 week | After 4 weeks | After 8 weeks | After 12 weeks | Total sealings evaluated | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | A | B | C | A | B | C | A | B | C | A | B | C | A | B | C | ||
| Resin-based sealant | Retention | 39 | 0 | 0 | 39 | 0 | 0 | 39 | 0 | 0 | 37 | 1 | 0 | 37 | 1 | 0 | 38 |
| Marginal integrity | 39 | 0 | 0 | 39 | 0 | 0 | 39 | 0 | 0 | 37 | 1 | 0 | 37 | 1 | 0 | 38 | |
| Marginal discoloration | 39 | 0 | 0 | 39 | 0 | 0 | 39 | 0 | 0 | 38 | 0 | 0 | 38 | 0 | 0 | 38 | |
| Surface texture—optical | 39 | 0 | 0 | 39 | 0 | 0 | 39 | 0 | 0 | 38 | 0 | 0 | 38 | 0 | 0 | 38 | |
| Surface texture—tactile | 39 | 0 | 0 | 39 | 0 | 0 | 39 | 0 | 0 | 38 | 0 | 0 | 38 | 0 | 0 | 38 | |
| Caries | 39 | 0 | 0 | 39 | 0 | 0 | 39 | 0 | 0 | 38 | 0 | 0 | 38 | 0 | 0 | 38 | |
| Glass ionomer | Retention | 39 | 0 | 0 | 38 | 1 | 0 | 36 | 3 | 0 | 33 | 5 | 0 | 30 | 8 | 0 | 38 |
| Marginal integrity | 39 | 0 | 0 | 37 | 2 | 0 | 29 | 10 | 0 | 26 | 12 | 0 | 22 | 16 | 0 | 38 | |
| Marginal discoloration | 39 | 0 | 0 | 39 | 0 | 0 | 39 | 0 | 0 | 38 | 0 | 0 | 38 | 0 | 0 | 38 | |
| Surface texture—optical | 39 | 0 | 0 | 39 | 0 | 0 | 21 | 18 | 0 | 10 | 28 | 0 | 8 | 30 | 0 | 38 | |
| Surface texture—tactile | 39 | 0 | 0 | 38 | 1 | 0 | 20 | 19 | 0 | 10 | 28 | 0 | 5 | 33 | 0 | 38 | |
| Caries | 39 | 0 | 0 | 39 | 0 | 0 | 39 | 0 | 0 | 38 | 0 | 0 | 38 | 0 | 0 | 38 | |